The federal government says it expects Canada to receive around 1.9 million doses of COVID-19 vaccines this week, including its very first shipment of single-dose shots from Johnson & Johnson.
Canada is set to receive about 300,000 doses of the J&J vaccine, which will come in addition to more than one million Pfizer-BioNTech shots and around 650,000 jabs from Moderna.
Canada does not currently have plans to receive an additional AstraZeneca vaccine, although it is in great demand after the age of eligibility for vaccination has fallen to 40 years in some provinces.
That demand is only expected to increase after the National Advisory Committee on Immunization adjusted its age recommendation for the shots, announcing on Friday that Canadians 30 and older should get the AstraZeneca vaccine.
Some provinces, however, have said they don’t have enough supply to expand eligibility any further.
Federal Public Procurement Minister Anita Anand said last week the government is in talks with the United States to secure additional AstraZeneca doses after President Joe Biden suggested his country might share the shots with Canada.
The United States has stockpiled in the tens of millions of AstraZeneca injections, but health officials there have yet to approve the vaccine.
Minister Anand said earlier this month that Canada still expects to receive 4.1 million doses of AstraZeneca from all sources by the end of June.
This week is the last week Canada has received less than two million doses of the Pfizer-BioNTech vaccine, as the pharmaceutical company prepares to ramp up deliveries in the near future.
The government expects the Pfizer-BioNTech injections to arrive early in the week and the Moderna injections around midweek.
This content is also available in: Tiếng Việt